Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) — Capital Reinvestment Ratio
Guangdong Zhongsheng Pharmaceutical Co Ltd (002317) has a Capital Reinvestment Ratio of 0.93x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥88.00 Million) in capital expenditures (CN¥82.19 Million). Check Guangdong Zhongsheng Pharmaceutical Co L tangible equity quality to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangdong Zhongsheng Pharmaceutical Co Ltd Capital Reinvestment Ratio (2006–2024)
This chart tracks Guangdong Zhongsheng Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 19 annual periods. For the full cash flow conversion analysis, see Guangdong Zhongsheng Pharmaceutical Co L (002317) cash flow conversion.
Annual Capital Reinvestment Ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd (2006–2024)
Year-by-year Capital Reinvestment Ratio for Guangdong Zhongsheng Pharmaceutical Co Ltd from 2006 to 2024. See free cash flow generation of Guangdong Zhongsheng Pharmaceutical Co L to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.68x | CN¥337.84 Million | CN¥228.26 Million | ▼ -64.5% |
| 2023 | 1.90x | CN¥190.61 Million | CN¥363.06 Million | ▼ -55.2% |
| 2022 | 4.25x | CN¥63.07 Million | CN¥267.96 Million | ▲ +1137.8% |
| 2021 | 0.34x | CN¥622.77 Million | CN¥213.76 Million | ▼ -69.1% |
| 2020 | 1.11x | CN¥138.93 Million | CN¥154.43 Million | ▲ +117.5% |
| 2019 | 0.51x | CN¥251.16 Million | CN¥128.33 Million | ▲ +16.4% |
| 2018 | 0.44x | CN¥326.78 Million | CN¥143.48 Million | ▲ +30.7% |
| 2017 | 0.34x | CN¥369.91 Million | CN¥124.28 Million | ▼ -19.5% |
| 2016 | 0.42x | CN¥338.28 Million | CN¥141.19 Million | ▲ +4.8% |
| 2015 | 0.40x | CN¥192.25 Million | CN¥76.57 Million | ▼ -79.9% |
| 2014 | 1.98x | CN¥100.60 Million | CN¥199.54 Million | ▲ +96.7% |
| 2013 | 1.01x | CN¥110.95 Million | CN¥111.91 Million | ▲ +85.5% |
| 2012 | 0.54x | CN¥142.38 Million | CN¥77.42 Million | ▼ -79.3% |
| 2011 | 2.63x | CN¥70.56 Million | CN¥185.41 Million | ▲ +259.6% |
| 2010 | 0.73x | CN¥91.72 Million | CN¥67.02 Million | ▲ +222.9% |
| 2009 | 0.23x | CN¥100.89 Million | CN¥22.83 Million | ▼ -15.4% |
| 2008 | 0.27x | CN¥72.86 Million | CN¥19.49 Million | ▼ -48.6% |
| 2007 | 0.52x | CN¥49.35 Million | CN¥25.67 Million | ▼ -5.4% |
| 2006 | 0.55x | CN¥17.91 Million | CN¥9.84 Million | — |